84-4333-95 ADAR2 (ADARB1, ADAR2, DRADA2, RED1, Double-stranded RNA-specific editase 1, RNA-editing deaminase 1, RNA-editing enzyme 1, dsRNA adenosine deaminase) 100ul 304847

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing.
  • This may affect gene expression and function in a number of ways that include mRNA translation by changing codons and hence the amino acid sequence of proteins; pre-mRNA splicing by altering splice site recognition sequences; RNA stability by changing sequences involved in nuclease recognition; genetic stability in the case of RNA virus genomes by changing sequences during viral RNA replication; and RNA structure-dependent activities such as microRNA production or targeting or protein-RNA interactions.
  • Can edit both viral and cellular RNAs and can edit RNAs at multiple sites (hyper-editing) or at specific sites (site-specific editing).
  • Its cellular RNA substrates include: bladder cancer-associated protein (BLCAP), neurotransmitter receptors for glutamate (GRIA2 and GRIK2) and serotonin (HTR2C), GABA receptor (GABRA3) and potassium voltage-gated channel (KCNA1).
  • Site-specific RNA editing of transcripts encoding these proteins results in amino acid substitutions which consequently alter their functional activities.
  • Edits GRIA2 at both the Q/R and R/G sites efficiently but converts the adenosine in hotspot1 much less efficiently.
  • Can exert a proviral effect towards human immunodeficiency virus type 1 (HIV-1) and enhances its replication via both an editing-dependent and editing-independent mechanism.
  • The former involves editing of adenosines in the 5'UTR while the latter occurs via suppression of EIF2AK2/PKR activation and function.
  • Can inhibit cell proliferation and migration and can stimulate exocytosis.Mittaz L., Genomics 41:210-217(1997).
  • Lai F., Mol.
  • Cell.
  • Biol.
  • 17:2413-2424(1997).
  • Villard L., Somat.
  • Cell Mol.
  • Genet.
  • 23:135-145(1997).
  • Applications:Suitable for use in Western Blot.
  • Other applications not tested.
  • Recommended Dilution:Western Blot: 1:500-1:3000Optimal dilutions to be determined by the researcher.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Aliquots are stable for 12 months after receipt.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by immunoaffinity chromatography.
  • Form:Supplied as a liquid in PBS, pH 7.4, 150mM sodium chloride, 0.02% sodium azide, 50% glycerol.
  • Specificity:Recognizes human ADAR2. Species Crossreactivity: mouse and rat
  • Isotype:IgG
  • Calc Applications Abbrev:WB
  • Calc Crossreactivity:Hu Mo Rt
  • Immunogen:Synthetic peptide corresponding to internal of human ADAR2.
  • Shelf Life:1year
  • Swiss Prot Number:P78563
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-4333-95
型番
304847
入り数
1個
標準価格
129,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る